NeuroMD is a medical technology company founded in 2017 by CEO Anthony Rumbello. They specialize in FDA cleared, at home bioelectronic devices designed to treat chronic lower back pain. Their primary product, the Corrective Therapy Device, uses Neuromuscular Electrical Stimulation (NMES) to stimulate motor nerves. This technology forces back and core muscles to contract, mimicking exercise to stabilize the spine, increase localized blood flow, and heal damaged tissues.
